NF-κB in Thyroid Cancer: An Update.

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• Nuclear factor-kappa B (NF-κB) dysregulation is prevalent in human thyroid carcinomas, particularly in aggressive, poorly differentiated, and undifferentiated subtypes.
• These advanced thyroid cancers often exhibit resistance to conventional therapies, leading to poor prognoses.

Purpose of the Study:

• To review recent findings on the critical roles of NF-κB in thyroid cancer pathogenesis.
• To explore the therapeutic potential of targeting NF-κB signaling in advanced thyroid carcinomas.

Main Methods:

• Literature review of recent studies on NF-κB signaling in thyroid cancer.
• Analysis of NF-κB's contribution to cancer cell proliferation, survival, migration, and microenvironment modulation.
• Examination of NF-κB's role in thyroid cancer stem cells.

Main Results:

• NF-κB enhances thyroid cancer cell proliferation, viability, and migration.
• NF-κB signaling fuels the tumor microenvironment and is crucial in cancer stem cells of aggressive thyroid carcinomas.
• While mechanisms are partially understood, NF-κB activation significantly contributes to thyroid cancer's oncogenic potential.

Conclusions:

• Targeting upstream or downstream NF-κB pathways presents a viable strategy for developing novel therapeutics.
• Interfering with NF-κB signaling may overcome therapy resistance in advanced thyroid carcinomas.
• NF-κB represents a key therapeutic target for improving outcomes in aggressive thyroid cancer.